The First Heart Failure Conference in Qatar, organised by Hamad Medical Corporation’s (HMC) Heart Hospital, is set to begin Thursday at Itqan Clinical Simulation and Innovation Centre.
The three-day conference, is the first of its kind in Qatar and one of the most important cardiology conferences in the region, bringing together a large gathering of cardiologists from Qatar, the Gulf, and around the world to discuss the most recent advances in the management of heart failure patients.
The programme includes lectures and sessions addressing the latest developments in medication treatment for heart muscle, the latest research findings, and the role of heart organisations in the advancement of heart failure management. There are also workshops and specialised lectures by international experts to discuss heart transplants, their approaches, and their importance for heart failure patients who do not respond to traditional treatments, as well as the treatment of heart conditions in cancer patients receiving chemotherapy and radiation.
Dr Nidal Asaad, CEO and medical director of the Heart Hospital said: "The conference hosts local, regional, and international experts in the field of heart failure. The aim of this conference is to improve healthcare provided for heart failure patients and enable our cardiologists to learn about the latest treatment methods, which is in line with HMC’s vision to provide the best care for patients."
Dr Asaad noted that HMC provides the most advanced medical equipment and modern technologies in the world for heart failure patients in the country, including a device for supporting the heart muscle in complex emergency cases, which contributes to the success of treatment of many cases. He added that ongoing endeavours are in progress to introduce a state-of-the-art remote heart monitoring device in the near future.
Dr Amr Badr, director of Heart Failure Clinics and chairman of the conference organising committee said: "The significance of this conference goes beyond bringing together the brightest minds in cardiology; it also serves as a testament to our collective commitment to improving the lives of heart failure patients."
The conference provides a scientific platform to review the latest research, best care practices, and innovative ideas, along with promoting collaboration and innovation that will reshape the landscape of cardiovascular patient care.
Dr Badr emphasised that the conference will contribute to making a positive impact on the lives of heart failure patients, enhancing the quality of healthcare, and advancing the scientific expertise of healthcare professionals within the Heart Hospital and HMC.
Dr Nidal Asaad
Dr Amr Bader
